BOARD OF DIRECTORS

CHAIRMAN*

David R. Margrave
BioNumerik Pharmaceuticals, Inc.

 

VICE CHAIRMAN*

Robert W. Gracy, Ph.D.
University of Texas at San Antonio

 

SECRETARY*

Open

 

TREASURER*

Richard B. Ponder
Johnson & Johnson

 

PRESIDENT*

Thomas R. Kowalski
Texas Healthcare and Bioscience Institute

 

THBI Board of Directors

Brent Byler
Allergan, Inc.

Dr. James A. Calvin
Texas A&M University

Tracey Davies
Vinson & Elkins, LLP

Charles R. Grezlak, Ph.D.
Merck & Co., Inc.

Frank Jackson
Bristol-Myers Squibb Company

Robert W. Jones
Pfizer

Tim Martin
AmGen, Inc.

Wes Metheny
PhRMA

Walter Moore
Genentech, Inc.

Susan Morris
Kinetic Concepts, Inc.

David Nance
Introgen Therapeutics

Frank Plescia
Monsanto Company

Pike Powers
Fulbright & Jaworski, L.L.P.

Meg Propes
AstraZeneca

Don Stevens
Novartis Pharmaceuticals

Rodney Varner
THBI General Counsel
Wilson & Varner, L.L.P.

Jeffrey L. Wade*
Lexicon Genetics Incorporated

Keith Wood
Wyeth Pharmaceuticals

Michael J. Wright*
Hoffmann-La Roche Inc.

 

* DENOTES EXECUTIVE COMMITTEE